APOA1 and Insulin resistance: Recently, SNPs in APOA1 have been widely utilized as predictive markers for CAD risk, and prospective studies of weight loss in obese patients have shown that the APOA1 (rs670) gene displays significant effects on LDL cholesterol levels and insulin resistance [14,15,16].